|Listen:||Note: There is multimedia content on this page which requires the Flash viewer. To see it, download and install the Flash plugin here: Macromedia Flash Player|
Overview: The H1N1 influenza virus has been declared a global pandemic, and the first national vaccine trials are getting underway to develop a vaccine to protect people against the virus. Researchers at the University of Maryland Center for Vaccine Development are leading the efforts. In this Medically Speaking podcast, lead investigator Dr. Karen Kotloff describes the nationwide study that she and colleagues will conduct in 1,000 volunteers. The researchers will evaluate the vaccine’s safety and its ability to stimulate immunity to the H1N1 virus among children, adults and seniors.
In this interview with Karen Buckelew, Dr. Kotloff explains that genetic differences between the H1N1 flu and seasonal flu require an entirely new vaccine in order to be protected. She says the study is the first step toward making a vaccine available to the public by the time the flu season begins in the fall, when the pandemic flu is expected to reemerge. Dr. Kotloff is a pediatrician at the University of Maryland Medical Center and a professor of pediatrics and medicine and a researcher at the University of Maryland School of Medicine’s Center for Vaccine Development.
We would like your feedback about Medically Speaking. If you'd like to contact us, please e-mail firstname.lastname@example.org.